Intravenous immunoglobulin for the treatment of clostridium difficile infection: A review

Digestive Diseases and Sciences

Volumn 56, Issue 1, 2011, Pages 19-26

  Abougergi, Marwan S ^a   Kwon, John H ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Clostridium difficile drug effects; Immunoglobulins; Immunomodulation; Infectious diarrhea; Intravenous therapeutic use; Nosocomial infection

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN A ANTIBODY; CLOSTRIDIUM DIFFICILE TOXIN B; CLOSTRIDIUM DIFFICILE TOXIN B ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METRONIDAZOLE; NEUTRALIZING ANTIBODY; TOXIN ANTIBODY; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBODY RESPONSE; B LYMPHOCYTE; BACTERIAL COLONIZATION; BACTERIAL IMMUNITY; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DISEASE DURATION; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMORAL IMMUNITY; ILEOCECITIS; IMMUNE RESPONSE; IMMUNOMODULATION; NONHUMAN; OUTCOME ASSESSMENT; PASSIVE IMMUNIZATION; PHAGOCYTOSIS; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; REVIEW; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CRICETINAE; DIARRHEA; DISEASE MODELS, ANIMAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79151476267     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1411-2     Document Type: Review

References (60)

1. LK Archibald SN Banerjee WR Jarvis 2004 Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001 J Infect Dis 189 1585 1859 10.1086/383045 15116293
2. L Kyne MB Hamel R Polavaram CP Kelly 2002 Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile Clin Infect Dis 34 346 353 10.1086/338260 11774082
3. ER Dubberke KA Reske MA Olsen LC McDonald VJ Fraser 2008 Short-and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients Clin Infect Dis 46 497 504 10.1086/526530 18197759
4. LC McDonald GE Killgore A Thompson, et al. 2005 An epidemic, toxin gene-variant strain of Clostridium difficile N Engl J Med 353 2433 2441 1:CAS:528:DC%2BD2MXhtlShurvP 10.1056/NEJMoa051590 16322603
5. RM Dallal BG Harbrecht AJ Boujoukas, et al. 2002 Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications Ann Surg 235 363 372 10.1097/00000658-200203000-00008 11882758
6. VG Loo L Poirier MA Miller, et al. 2005 A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality N Engl J Med 353 2442 2449 1:CAS:528: DC%2BD2MXhtlShurvK 10.1056/NEJMoa051639 16322602
7. LC McDonald M Owings DB Jernigan 2006 Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003 Emerg Infect Dis 12 409 515 16704777
8. J Pepin L Valiquette ME Alary, et al. 2004 Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity Cmaj 171 466 472 15337727
9. LV McFarland CM Surawicz WE Stamm 1990 Risk factors for Clostridium difficile carriage, C. difficile-associated diarrhea in a cohort of hospitalized patients J Infect Dis 162 678 684 1:STN:280:DyaK3czlsVOjuw%3D%3D 2387993
10. S Aslam RJ Hamill DM Musher 2005 Treatment of Clostridium difficile-associated disease: old therapies and new strategies Lancet Infect Dis 5 549 557 1:CAS:528:DC%2BD2MXhtVGltLjF 10.1016/S1473-3099(05)70215-2 16122678
11. P Gianfrilli I Luzzi A Pantosti M Occhionero G Gentile G Panichi 1984 Cytotoxin and enterotoxin production by Clostridium difficile Microbiologica 7 375 379 1:CAS:528:DyaL2MXht1ymsL8%3D 6513801
12. DM Lyerly KE Saum DK MacDonald TD Wilkins 1985 Effects of Clostridium difficile toxins given intragastrically to animals Infect Immun 47 349 352 1:CAS:528:DyaL2MXhtVOrtbc%3D 3917975
13. M Riegler R Sedivy C Pothoulakis, et al. 1995 Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro J Clin Invest 95 2004 2011 1:CAS:528:DyaK2MXltlWrtrw%3D 10.1172/JCI117885 7738167
14. D Lyras JR O'Connor PM Howarth, et al. 2009 Toxin B is essential for virulence of Clostridium difficile Nature 458 1176 1179 1:CAS:528: DC%2BD1MXisVOrtLg%3D 10.1038/nature07822 19252482
15. A Fernandez G Anand F Friedenberg 2004 Factors associated with failure of metronidazole in Clostridium difficile-associated disease J Clin Gastroenterol 38 414 418 1:CAS:528:DC%2BD2cXkvFKitb0%3D 15100520
16. S Aslam RJ Hamill DM Musher 2005 Treatment of Clostridium difficile-associated disease: old therapies and new strategies Lancet Infect Dis 5 549 557 1:CAS:528:DC%2BD2MXhtVGltLjF 10.1016/S1473-3099(05)70215-2 16122678
17. DM Musher S Aslam N Logan, et al. 2005 Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole Clin Infect Dis 40 1586 1590 1:CAS:528:DC%2BD2MXltlCltLo%3D 10.1086/430311 15889354
18. FA Zar SR Bakkanagari KM Moorthi MB Davis 2007 A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity Clin Infect Dis 45 302 307 1:CAS:528:DC%2BD2sXptVKnur8%3D 10.1086/519265 17599306
19. EJ Kuijper B Coignard JS Brazier, et al. 2007 Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe Euro Surveill 12 E1 E2 1:STN:280:DC%2BD2snms1yntw%3D%3D 17991399
20. M Allo J Silva Jr R Fekety GD Rifkin H Waskin 1979 Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin Gastroenterology 76 351 355 1:CAS:528:DyaE1MXhtF2mu7k%3D 759263
21. PH Kim JP Iaconis RD Rolfe 1987 Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters Infect Immun 55 2984 2992 1:STN:280:DyaL1c%2FlslGrtQ%3D%3D 3679541
22. DM Lyerly EF Bostwick SB Binion TD Wilkins 1991 Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate Infect Immun 59 2215 2218 1:CAS:528: DyaK3MXkvFSns78%3D 2037383
23. JA Kink JA Williams 1998 Antibodies to recombinant Clostridium difficile toxins A, B are an effective treatment, prevent relapse of C. difficile-associated disease in a hamster model of infection Infect Immun 66 2018 2025 1:CAS:528:DyaK1cXivFKqsb4%3D 9573084
24. R Viscidi BE Laughon R Yolken, et al. 1983 Serum antibody response to toxins A and B of Clostridium difficile J Infect Dis 148 93 100 1:STN:280:DyaL3s3pt1ynsQ%3D%3D 6886489
25. DY Leung CP Kelly M Boguniewicz C Pothoulakis JT LaMont A Flores 1991 Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin J Pediatr 118 633 637 1:STN:280:DyaK3M7nvVKjsQ%3D%3D 10.1016/S0022-3476(05)83393-1 1901084
26. AE Bacon III R Fekety 1994 Immunoglobulin G directed against toxins A and B of Clostridium difficile in the general population and patients with antibiotic-associated diarrhea Diagn Microbiol Infect Dis 18 205 209 10.1016/0732-8893(94)90021-3 7924215
27. B Aronsson M Granstrom R Mollby CE Nord 1985 Serum antibody response to Clostridium difficile toxins in patients with Clostridium difficile diarrhoea Infection 13 97 101 1:STN:280:DyaL2M3oslKjsA%3D%3D 10.1007/BF01642866 4030111
28. B Aronsson M Granstrom R Mollby CE Nord 1983 Enzyme-linked immunosorbent assay (ELISA) for antibodies to Clostridium difficile toxins in patients with pseudomembranous colitis and antibiotic-associated diarrhoea J Immunol Methods 60 341 350 1:STN:280:DyaL3s3hsVOjtg%3D%3D 10.1016/0022-1759(83)90291-0 6854035
29. S Johnson DN Gerding EN Janoff 1992 Systemic and mucosal antibody responses to toxin A in patients infected with Clostridium difficile J Infect Dis 166 1287 1294 1:STN:280:DyaK3s%2Fls1Kqtw%3D%3D 1431247
30. ME Mulligan SD Miller LV McFarland HC Fung RY Kwok 1993 Elevated levels of serum immunoglobulins in asymptomatic carriers of Clostridium difficile Clin Infect Dis 16 Suppl 4 S239 S244 8324125
31. M Warny JP Vaerman V Avesani M Delmee 1994 Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection Infect Immun 62 384 389 1:CAS:528:DyaK2cXhs1Wntrg%3D 8300199
32. L Kyne M Warny A Qamar CP Kelly 2000 Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A N Engl J Med 342 390 397 1:STN:280:DC%2BD3c7hs12mtg%3D%3D 10.1056/NEJM200002103420604 10666429
33. L Kyne M Warny A Qamar CP Kelly 2001 Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea Lancet 357 189 193 1:CAS:528:DC%2BD3MXptVyruw%3D%3D 10.1016/S0140-6736(00)03592-3 11213096
34. K Katchar CP Taylor S Tummala X Chen J Sheikh CP Kelly 2007 Association between IgG2 and IgG3 subclass responses to toxin A and recurrent Clostridium difficile-associated disease Clin Gastroenterol Hepatol 5 707 713 1:CAS:528:DC%2BD2sXnsFSltb4%3D 10.1016/j.cgh.2007.02.025 17544998
35. J Hassett S Meyers L McFarland ME Mulligan 1995 Recurrent Clostridium difficile infection in a patient with selective IgG1 deficiency treated with intravenous immune globulin and Saccharomyces boulardii Clin Infect Dis 20 Suppl 2 S266 S268 7548571
36. J Salcedo S Keates C Pothoulakis, et al. 1997 Intravenous immunoglobulin therapy for severe Clostridium difficile colitis Gut 41 366 370 1:CAS:528:DyaK2sXms1Shs70%3D 10.1136/gut.41.3.366 9378393
37. M Warny C Denie M Delmee C Lefebvre 1995 Gamma globulin administration in relapsing Clostridium difficile-induced pseudomembranous colitis with a defective antibody response to toxin A Acta Clin Belg 50 36 39 1:STN:280:DyaK2M3kt1yrsw%3D%3D 7537003
38. A Vernet G Corthier F Dubos-Ramare AL Parodi 1989 Relationship between levels of Clostridium difficile toxin A and toxin B and cecal lesions in gnotobiotic mice Infect Immun 57 2123 2127 1:CAS:528:DyaL1MXkslGltrc%3D 2499546
39. G Corthier MC Muller TD Wilkins D Lyerly R L'Haridon 1991 Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A Infect Immun 59 1192 1195 1:CAS:528:DyaK3MXhs1aisLg%3D 1900059
40. GJ Babcock TJ Broering HJ Hernandez, et al. 2006 Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters Infect Immun 74 6339 6347 1:CAS:528:DC%2BD28Xht1Khu7zN 10.1128/IAI.00982-06 16966409
41. C Ghose A Kalsy A Sheikh, et al. 2007 Transcutaneous immunization with Clostridium difficile toxoid A induces systemic and mucosal immune responses and toxin A-neutralizing antibodies in mice Infect Immun 75 2826 2832 1:CAS:528:DC%2BD2sXmtlKms7w%3D 10.1128/IAI.00127-07 17371854
42. CP Kelly C Pothoulakis J Orellana JT LaMont 1992 Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding Gastroenterology 102 35 40 1:CAS:528:DyaK38XhtVCjs78%3D 1309359
43. S Johnson WD Sypura DN Gerding SL Ewing EN Janoff 1995 Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal disease Infect Immun 63 3166 3173 1:CAS:528:DyaK2MXntFyqtbc%3D 7622244
44. SS Johal CP Lambert J Hammond PD James SP Borriello YR Mahida 2004 Colonic IgA producing cells and macrophages are reduced in recurrent and non-recurrent Clostridium difficile associated diarrhoea J Clin Pathol 57 973 979 1:STN:280:DC%2BD2cvivVCgug%3D%3D 10.1136/jcp.2003.015875 15333661
45. D Drudy E Calabi L Kyne, et al. 2004 Human antibody response to surface layer proteins in Clostridium difficile infection FEMS Immunol Med Microbiol 41 237 242 1:CAS:528:DC%2BD2cXkvVKksLs%3D 10.1016/j.femsim.2004.03.007 15196573
46. JB O'Brien MS McCabe V Athie-Morales GS McDonald DB Ni Eidhin DP Kelleher 2005 Passive immunisation of hamsters against Clostridium difficile infection using antibodies to surface layer proteins FEMS Microbiol Lett 246 199 205 10.1016/j.femsle.2005.04.005 15899406
47. IL Beales 2002 Intravenous immunoglobulin for recurrent Clostridium difficile diarrhoea Gut 51 456 1:STN:280:DC%2BD38vhvVSrsg%3D%3D 10.1136/gut.51.3.456 12171976
48. A Hassoun F Ibrahim 2007 Use of intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis Am J Geriatr Pharmacother 5 48 51 10.1016/j.amjopharm.2007.03.001 17608247
49. P Juang SJ Skledar NK Zgheib, et al. 2007 Clinical outcomes of intravenous immune globulin in severe Clostridium difficile-associated diarrhea Am J Infect Control 35 131 137 10.1016/j.ajic.2006.06.007 17327194
50. S McPherson CJ Rees R Ellis S Soo SJ Panter 2006 Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea Dis Colon Rectum 49 640 645 10.1007/s10350-006- 0511-8 16525744
51. C Murphy M Vernon M Cullen 2006 Intravenous immunoglobulin for resistant Clostridium difficile infection Age Ageing 35 85 86 1:STN:280: DC%2BD2Mnns1Cgsg%3D%3D 10.1093/ageing/afi212 16303776
52. MH Wilcox 2004 Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea J Antimicrob Chemother 53 882 884 1:CAS:528:DC%2BD2cXjs1Wqt7w%3D 10.1093/jac/dkh176 15073160
53. LA Cone C Lopez HL Tarleton, et al. 2006 A durable response to relapsing Clostridium difficile colitis may require combined therapy with high-dose oral vancomycin and intravenous immune globulin Infect Dis Clin Pract 14 217 220 10.1097/01.idc.0000222619.48650.d2
54. T Chandrasekar N Naqvi A Waddington, et al. 2008 Intravenous immunoglobulin therapy for refractory Clostridium difficile toxin colitis in chronic kidney disease: case reports and literature review Nephrol Dial Transplant 1 20 22
55. A Koulaouzidis R Tatham J Moschos CW Tan 2008 Successful treatment of Clostridium difficile colitis with intravenous immunoglobulin J Gastrointestin Liver Dis 17 353 355
56. MS Abougergi A Broor W Cui BG Jaar 2010 Intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis: an observational study and review of the literature J Hosp Med 5 E1 E9 10.1002/jhm.542 20063275
57. S Grover MJ Hamilton DL Carr-Locke 2007 Refractory Clostridium difficile-associated diarrhea MedGenMed 9 46 17955101
58. I Lowy DC Molrine BA Leav, et al. 2010 Treatment with monoclonal antibodies against Clostridium difficile toxins N Engl J Med 362 197 205 1:CAS:528:DC%2BC3cXosFShtw%3D%3D 10.1056/NEJMoa0907635 20089970
59. MS Rubin LE Bodenstein KC Kent 1995 Severe Clostridium difficile colitis Dis Colon Rectum 38 350 354 1:STN:280:DyaK2M3js1ymuw%3D%3D 10.1007/BF02054220 7720439
60. M Warny A Fatimi EF Bostwick, et al. 1999 Bovine immunoglobulin concentrate-a retains C difficile toxin neutralising activity after passage through the human stomach and small intestine Gut 44 212 217 1:STN:280:DyaK1M7ht12rtQ%3D%3D 10.1136/gut.44.2.212 9895380